.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Medical seat expansion in India has reached a significant milestone. The Central government recently approved 10,023 new seats across various government institutions. Consequently, this move aims to bridge the gap between healthcare demand and the current medical workforce. This expansion includes a mix of undergraduate and postgraduate positions to ensure balanced growth.
The Ministry of Health cleared 5,023 MBBS seats and 5,000 postgraduate seats. Furthermore, the implementation will occur between 2025 and 2029. This Phase-III Centrally Sponsored Scheme strengthens existing state medical colleges. Moreover, the cost ceiling per seat has risen to ₹1.50 crore due to higher infrastructure expenses. However, the government prioritizes underserved and rural areas for these new additions.
The National Medical Commission (NMC) notified updated regulations to support this growth. Specifically, they widened eligibility norms for faculty members. Additionally, more hospitals now qualify as teaching institutions. These changes facilitate a smoother transition for new students and staff alike. States must now submit detailed project reports to secure funding for these projects.
Q1: How many postgraduate seats were added in this scheme?
The government approved 5,000 additional postgraduate seats to address the shortage of specialists in the country.
Q2: What is the new cost ceiling per medical seat?
The cost ceiling has been increased to ₹1.5 crore per seat to accommodate rising infrastructure and equipment costs.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The Indian government has cleared 10,023 new medical seats (5,023 MBBS, 5,000 PG) under a Phase-III scheme with a cost ceiling of ₹1.5 crore per seat....
8 months ago
An elderly man with partially repaired Tetralogy of Fallot presented with STEMI caused by coronary embolism rather than atherosclerosis. Successful treatment with sustained mechanical aspiration thrombectomy underscores the vital need for high clinical vigilance in adult congenital heart disease.
Today
Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today
A recent study demonstrates that spinal oxygen sensors do not require mitochondrial electron transport to trigger sympathetic excitation during acute hypoxia, revealing new insights into how mitochondrial oxidative stress modulates autonomic tone in cardiovascular and neurological diseases.
Today
A novel calcium polyphosphate coacervate enables injectable bone implants with in situ hierarchical porosity via phase separation and gas foaming, significantly enhancing cell proliferation, energy metabolism, and osteogenic differentiation for minimally invasive bone defect repair.
Today
Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today
